Study of Capecitabine to Treat Recurrent High Grade Gliomas
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if capecitabine is effective in the treatment of
high grade gliomas that have returned after completing treatment.